KemPharm, Inc. Receives Patent from the USPTO for Novel Pain Drug Candidate, KP201

by admin on June 11, 2013

NORTH LIBERTY, Iowa, June 11, 2013 /PRNewswire/ — KemPharm, Inc., a clinical stage biopharmaceutical company focused on the discovery and development of new, safer therapies to treat pain, announced today …

View full post on pain – Yahoo! News Search Results

Previous post:

Next post: